Multi-pronged strategy to support the prevention of diabetes and heart disease

Published Date: 08 Mar 2023

Interventions to improve clinical practice increased the odds that people with type 2 diabetes and heart disease were prescribed the drugs recommended in our study by more than 100%.

Read Full News

Latest News

Insulin rationing persists despite policy changes, study shows

Yale researchers have found that despite new policies addressing insulin costs, the proportion of patients who ration insulin due to cost remains unchanged. The findings were published in the Journal of General Internal Medicine.

Why your daily walk might not work as well if you're on metformin

A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise.

Maternal type 1 diabetes may protect children through epigenetic changes

Type 1 diabetes is an autoimmune disease in which the immune system destroys the body's own insulin-producing beta-cells in the pancreas, leaving patients with a lifelong dependency on external insulin.

Human stomach cells tweaked to produce insulin in diabetes treatment study

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and is estimated to affect 9.5 million people worldwide.

Finerenone reduces kidney damage in type 1 diabetes by lowering protein in urine

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction indicates that the degree ...

Therapies against cellular aging may help treat metabolic diseases

A growing body of evidence implicates cellular senescence—when cells age and permanently stop dividing—as an important contributor to metabolic dysfunction that can lead to obesity, type 2 diabetes, and metabolic syndrome.

Todays Updates

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.

New study elucidates obesity's role in fueling breast cancer progression

Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...

Todays Updates

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.

New study elucidates obesity's role in fueling breast cancer progression

Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...

Latest News

Yale researchers have found that despite new policies addressing insulin costs, the proportion of patients who ration insulin due to cost remains unchanged. The findings were published in the Journal of General Internal Medicine.

A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise.

Type 1 diabetes is an autoimmune disease in which the immune system destroys the body's own insulin-producing beta-cells in the pancreas, leaving patients with a lifelong dependency on external insulin.

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and is estimated to affect 9.5 million people worldwide.

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction indicates that the degree ...

A growing body of evidence implicates cellular senescence—when cells age and permanently stop dividing—as an important contributor to metabolic dysfunction that can lead to obesity, type 2 diabetes, and metabolic syndrome.

News All Time

Bariatric surgery in a pill bottle

More than 37 million Americans have type 2 diabetes, a chronic disorder affecting the body's ability to regulate and use sugar. According to the CDC, it's the country's seventh leading cause of death. Type 2 diabetes can ...

Early trigger of diabetic eye disease identified

A team led by UCL scientists has identified a key protein that triggers diabetic retinopathy—a condition caused by high blood sugar damaging the retina's blood vessels and a leading cause of sight loss among working-age ...

African-Caribbean ethnicity key risk factor for sight-threatening diabetic eye disease

People of African-Caribbean ethnicity with Type 2 diabetes are a third more likely to develop a condition called sight-threatening diabetic retinopathy (STDR) than other ethnic groups, according to researchers from King's.

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

Nearly one-third of people with type 2 diabetes (T2D) in an Indian cohort have achieved remission through an intensive lifestyle intervention program, according to a study published in PLOS One by Pramod Tripathi of the Freedom ...

It's not just diet: Where a child lives can also raise type 2 diabetes risk

Type 2 diabetes (T2D), once considered an adult-onset disease, is increasing at alarming rates in children and adolescents. Before the mid-1990s, just 1% to 2% of youth with diabetes had T2D. Today, that number has skyrocketed ...

California to launch insulin for just $11 a pen

California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for folks with diabetes.

Assessing future physicians' awareness of diabetes stigma in health care

For people with medical conditions, stigma is a real problem they must worry about on top of their health. Stereotypes about health conditions often cause discrimination even by health care providers, as many may assume those ...

New study sheds light on gaps in post-hospital care for steroid-induced hyperglycemia

A recent study has revealed critical insights into the challenges faced by patients, families, and clinicians in managing steroid-induced hyperglycemia (SIH) after hospital discharge.

Vegan diet can help people with type 1 diabetes cut insulin costs by 27%

A low-fat vegan diet that doesn't limit calories or carbohydrates could help people with type 1 diabetes reduce insulin use and insulin costs, according to new research by the Physicians Committee for Responsible Medicine ...

Type 1 diabetes increased among young people during the pandemic

During the COVID-19 pandemic, there was an unexpected increase in the number of cases of type 1 diabetes in Sweden, particularly among children under 5 and young adult men. The infection accelerated the onset of diabetes ...

New diagnosis code for patients with type 2 diabetes in remission

Use lifestyle interventions to show no signs of type 2 diabetes for at least three months? There's a code for that: E11.A.

New gene therapy shows promise in preventing kidney disease in type 1 diabetes

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a University of Bristol ...

Optical imaging technique unlocks hidden glycemic history for diabetes and cancer research

A National Taiwan University (NTU) interdisciplinary research team, led by Prof. Chi-Kuang Sun and Prof. Tzung-Dau Wang, has unveiled a optical imaging technique that enables the reconstruction of an individual's historical ...

Diabetic teens with high blood sugar found to have higher neuropathy risk in adulthood

Poor blood sugar control in adolescence increases the risk of painful future complications for people with type 1 diabetes, research co-led by University of Michigan suggests.

Specialized cell discovery could improve type 1 diabetes prevention and treatment

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a critical hormone that regulates blood sugar in the body. Scientists at Scripps Research have discovered ...

'Smart insulin' shows promise in reducing hypoglycemia bouts

Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a lab-designed protein, possibly opening the door to a new treatment avenue for people with type 1 ...

Recommended News For You

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

Screening for prostate cancer: is it time to give up digital rectal examination?

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

'Sugar' signatures help identify and classify pancreatic cancer cell subtypes

Immunotherapy after surgery is good for patients with advanced cancer

Recommended Articles For You

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights 

Uncovering the Mystery of the Sessile Serrated Adenoma 

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy 

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chromatin organization linked to p53 tumor suppression mechanism

2.

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

3.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

4.

Patients face high out-of-pocket costs after incident cancer diagnosis

5.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

1.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

2.

HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review

3.

Glycopyrrolate: The Secret Weapon for Excessive Sweating 

4.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

5.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot